These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1802588)

  • 1. Isolation of low-molecular-weight peptides in hemofiltrated patients with cardiogenic shock: a new aspect of myocardial depressant substances.
    Coraim F; Trubel W; Ebermann R; Werner T
    Contrib Nephrol; 1991; 93():237-40. PubMed ID: 1802588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characterization of a myocardial depressant factor isolated from dogs with cardiogenic shock].
    Okuda M; Yamada T; Hosono K
    Jpn Circ J; 1973 Aug; 37(8):1009-17. PubMed ID: 4800821
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial depressant factor. A peptide: its significance in cardiogenic shock.
    Okuda M; Fukui T
    Jpn Circ J; 1974 Jun; 38(6):497-508. PubMed ID: 4436943
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Myocardial depressant factor (MDF) in cardiogenic shock.
    Vaisrub S
    JAMA; 1974 Apr; 228(4):500. PubMed ID: 4406217
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Myocardial depressant factor in cardiogenic shock.
    Wangensteen SL; Crampton RS; Ferguson WW
    JAMA; 1974 Jun; 228(13):1638-9. PubMed ID: 4406660
    [No Abstract]   [Full Text] [Related]  

  • 6. Intropic and electrophysiological action of humoral factors released in cardiogenic shock after acute myocardial infarction.
    Senges J; Mizutani T; Pelzer D; Brachmann J; Hennig E; Mehmel HC; Mäurer W; Wieland H; Katus H; Kübler W
    Basic Res Cardiol; 1978; 73(2):147-59. PubMed ID: 656022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral factors in cardiogenic shock].
    Kölbel F; Veselý P
    Vnitr Lek; 1978 Jul; 24(7):657-60. PubMed ID: 676122
    [No Abstract]   [Full Text] [Related]  

  • 8. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
    Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
    Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of a myocardial depressant factor in cardiogenic shock.
    Glenn TM; Lefer AM; Martin JB; Lovett WL; Morris JN; Wangensteen SL
    Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serial changes in myocardial depressant factor (Lefer) activities in cardiogenic shock].
    Okuda N; Yamada T; Hashizume T; Hosono K
    Rinsho Byori; 1974 Oct; 22(10 Suppl):6. PubMed ID: 4475976
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of acid-base state with hemofiltration in circulatory shock in patients after open heart surgery.
    Coraim FI; Haumer H; Trubel W; Simon P
    Contrib Nephrol; 1991; 93():86-9. PubMed ID: 1802608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiogenic shock secondary to acute myocardial infarction managed with high volume hemofiltration: report of a case].
    da Costa D; Gabrielli L; Andresen M; Downey P; Castro P
    Rev Med Chil; 2009 Oct; 137(10):1357-62. PubMed ID: 20011944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effect of neurotransmitter by hemofiltration in cardiogenic shock patients after open heart surgery.
    Coraim FI; Owen A; Trubel W; Kassal H; Widhalm K
    Contrib Nephrol; 1991; 93():90-3. PubMed ID: 1686998
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and partial characterization of two biologically active peptides from porcine spinal cord.
    Xi GL; Hua JC; Chen RL; Zhang RB; Zou G; Gao YS
    Sci Sin; 1981 Jul; 24(7):1010-20. PubMed ID: 7256256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The interrelationship of doses and the pharmacological effects of cardiac peptides].
    Pavlenko VS; Andreeva LI; Ershov VI; Khavinson VKh; Khlystov VV
    Biull Eksp Biol Med; 1992 Jul; 114(8):171-3. PubMed ID: 1467483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on low molecular weight inotropic plasma substances in prolonged hypovolemic traumatic shock.
    Hallström S; Vogl C; Krösl P; Redl H; Schlag G
    Prog Clin Biol Res; 1987; 236A():591-7. PubMed ID: 3615453
    [No Abstract]   [Full Text] [Related]  

  • 17. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a pancreatic cardiodepressant factor.
    Sagher U; Rosen H; Sarel O; Becker Y
    Circ Shock; 1986; 19(3):319-27. PubMed ID: 3731406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of ultrafiltration hemodialysis in a female patient with acute myocardial infarction complicated by cardiogenic shock and acute renal failure].
    Nasekin VA; Potapov AV
    Anesteziol Reanimatol; 2005; (4):71. PubMed ID: 16206594
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
    Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
    Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.